Faculty

Urgency to Lower LDL-C: Expanding the Treatment Toolbox

Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA​

‍

Triglyceride Trouble: Addressing Another Lipid Risk

Pam R. Taub, MD

‍

Lipoprotein(a): Silent Risk, Emerging Answers

Michelle L. O'Donoghue, MD, MPH

‍

Targeting Inflammatory Risk: Fighting ‘Fire’ With New Formulations

Michael S. Garshik, MD, MS

‍

Audience Q&A and Panel Discussion

Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA​; Danielle Belardo, MD; Michael S. Garshik, MD, MS; Michelle L. O'Donoghue, MD, MPH; Pam R. Taub, MD